FDA recommends that companies re-examine UDI basics with new guidance on how to form a proper identifier. The UDI must be present on the label and packages via easily readable plain-text and automatic identification/data capture technology.
Infection control has been on the radar of various orthopaedic device companies, from start-up to top five. In the trauma market, technologies intended to minimize post-surgical infections are emerging as a potential solution to address rising healthcare costs.
Outsourcing innovation can optimize design, improve timeline performance and reduce cost. It requires collaboration between the OEM and supplier, strong internal relations at both companies and an understanding of each company's core competency.